Recent News
The Effectiveness of Cisplatin and Pemetrexed in Pericardial Mesothelioma
Out of all the types of mesothelioma, pericardial mesothelioma is one of the rarest forms, accounting for only 0.002% of all known diagnosed mesothelioma cases. Mesothelioma is caused by asbestos…
Amosite vs. Chrysotile Asbestos in Peritoneal Mesothelioma
Mesothelioma is rare and aggressive asbestos-caused cancer in which there is no cure. The cancer affects the lining that surrounds various organs and cavities in the body; most tumors are…
Confocal Laser Endomicroscopy in Pleural Malignancies
Purpose:To date, the different biopsy methods, such as CT-guided pleural biopsy, mediastinal biopsy, endosonography and thoracoscopy have their limitations in diagnosing pleural malignancies, such as mesothelioma. Sampling errors frequently occur resulting in the common histological finding of ‘non-specific pleuritic/fibrosis’, which presents a great uncertainty for clinicians and patients. Confocal laser endomicroscopy (CLE) provides real-time imaging on a cellular level, however data of CLE in pleural malignancies are lacking.
Opdivo, Yervoy, and Keytruda: Immunotherapy Options for Mesothelioma
Immunotherapy treatments are becoming known alternatives to chemotherapy in cancer patients who have had little success with traditional cancer treatments. With mesothelioma, often times first line treatments have little effect…
INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Purpose:The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies.
Determining and Prolonging Survival Rates In Mesothelioma
The average survival rate for mesothelioma after diagnosis is less than one year; however, certain individuals will survive longer than others, but the reason as to why this is, is…
Mesothelioma Awareness Day 2017
Mesothelioma Awareness Day, which takes place on Tuesday, September 26, 2017, aims to educate and inform society about the deadly cancer caused by asbestos exposure, and how funding is a…
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma (MesoRT)
Purpose:This is a monocentric prospective study of radiotherapy using accelerated hypofractionation with Tomotherapy in Malignant Pleural Mesothelioma (MPM) patients after pleurectomy / decortication (P / D) or biopsy. The treatment will be delivered using Tomotherapy, that allows to adopt dose accelerated hypofraction criteria. Treatment duration is 5 consecutive days.
Study: More Mesothelioma Diagnoses Are Discovered At Autopsy Than Clinically
A mesothelioma diagnosis often a grim one; fatality rates are high as there is no known cure. Treatment can help alleviate pain and symptoms, but more often than not, patients…
Trimodality Therapy Increases Survival; Immunotherapy Treatment Approved by FDA
Since mesothelioma is often difficult to treat, scientists and researchers look to combination treatments and therapies to improve chances of patients’ survival. There is no “one” treatment that is used…
